Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.66% | -25.28% | 64.72% | 430.44% | 129.50% |
| Total Depreciation and Amortization | -1.08% | -1.55% | 6.44% | 2.64% | 5.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.52% | 131.40% | 36.62% | -32.21% | 16.47% |
| Change in Net Operating Assets | 1,244.46% | 2.76% | -392.87% | -178.89% | -95.01% |
| Cash from Operations | 6.22% | 169.36% | 14.14% | 18.18% | 22.61% |
| Capital Expenditure | -12.76% | 28.77% | -9.73% | -169.98% | 14.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -243.08% | 99.41% | 1.82% | -- | -4,566.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -181.42% | -- | -180.09% | 25.01% | -230.55% |
| Cash from Investing | -105.56% | 56.86% | -239.04% | -7.04% | -406.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 43.33% | 133.57% | 131.32% | -9.42% | -52.87% |
| Repurchase of Common Stock | -259.65% | -430.28% | 98.22% | -4,740.58% | -4,631.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.51% | -136.44% | -11.16% | 49.72% | -9.54% |
| Cash from Financing | -308.09% | -439.34% | 102.86% | -77.88% | -263.62% |
| Foreign Exchange rate Adjustments | 169.14% | -95.84% | -187.40% | 194.30% | -87.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.09% | 77.05% | 110.77% | -4.51% | -32.97% |